319 related articles for article (PubMed ID: 9951439)
1. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
3. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
4. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
[TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
7. The association between pregnancy and human papilloma virus prevalence.
Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.
Grinsztejn B; Veloso VG; Levi JE; Velasque L; Luz PM; Friedman RK; Andrade AC; Moreira RI; Russomano F; Pilotto JH; Bastos FI; Palefsky J
Int J Infect Dis; 2009 Jan; 13(1):72-80. PubMed ID: 18632296
[TBL] [Abstract][Full Text] [Related]
9. Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group.
Hankins C; Lapointe N; Walmsley S
CMAJ; 1998 Dec; 159(11):1359-65. PubMed ID: 9861204
[TBL] [Abstract][Full Text] [Related]
10. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
[TBL] [Abstract][Full Text] [Related]
11. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
13. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.
Rowhani-Rahbar A; Hawes SE; Sow PS; Toure P; Feng Q; Dem A; Dembele B; Critchlow CW; N'Doye I; Kiviat NB
J Infect Dis; 2007 Sep; 196(6):887-94. PubMed ID: 17703420
[TBL] [Abstract][Full Text] [Related]
14. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
Moscicki AB; Ellenberg JH; Farhat S; Xu J
J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotypes in women from three clinical settings.
Chaturvedi AK; Dumestre J; Gaffga AM; Mire KM; Clark RA; Braly PS; Dunlap K; Beckel TE; Hammons AF; Kissinger PJ; Hagensee ME
J Med Virol; 2005 Jan; 75(1):105-13. PubMed ID: 15543579
[TBL] [Abstract][Full Text] [Related]
16. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
17. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
[TBL] [Abstract][Full Text] [Related]
19. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
[TBL] [Abstract][Full Text] [Related]
20. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
